NYSE: LLY
Eli Lilly & Co. (LLY)
Eli Lilly & Co. is a public company that reports to the U.S. Securities and Exchange Commission and trades on NYSE under the ticker LLY. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.
Key facts
- Ticker symbol
- LLY
- Exchange
- NYSE
- SEC CIK
- 59478
- Official filings
- SEC EDGAR
Research LLY
- Profile — Business description, headquarters, subsidiaries and corporate identifiers.
- Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
- SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
- Stock Analysis — Price chart, returns, technical indicators and related companies.
- News — Latest headlines and press coverage.
- Material Contracts — Material agreements filed as exhibits to SEC reports.
- Benchmark — Stock performance against the S&P 500, Nasdaq and economic indicators.
- Peer Comparison — Side-by-side financial ratios against industry peers.
Frequently asked questions
What is Eli Lilly & Co.'s stock ticker?
Eli Lilly & Co. trades under the ticker symbol LLY on NYSE. Its SEC Central Index Key (CIK) is 59478.
Where can I read Eli Lilly & Co.'s SEC filings?
The LLY SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Eli Lilly & Co. has filed, with AI analysis. The original documents are also on SEC EDGAR.
How can I analyze LLY's financial statements?
The LLY Financials page shows Eli Lilly & Co.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.
How does LLY compare with its peers and the market?
The LLY Peer Comparison page lines Eli Lilly & Co. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500 and Nasdaq.
For information only — not investment advice.